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Abstract
Whilst multi-lateral funding for HIV/AIDS dramatically increased from 2004 to 2008, it has largely plateaued in the
last 8 years. Across sub-Saharan Africa, up to 20 % of total spending on health is used for HIV services, and of this
over 85 % is estimated to come from international funding rather than in-country sources. In Uganda, the fiscal
liability to maintain services for all those who are currently receiving it is estimated to be as much as 3 % of Gross
Domestic Product (GDP). In order to meet the growing need of increased patient numbers and further ART
coverage the projected costs of comprehensive HIV care and treatment services will increase substantially. Current
access to HIV care includes free at point of delivery (provided by Ministry of Health clinics), as well as out-of-pocket
financing and health insurance provided care at private for- and not for- profit facilities. The HIV response is funded
through Ugandan Ministry of Health national budget allocations, as well as multilateral donations such as the
President’s Emergency Plan for AIDS in Africa (PEPFAR) and Global Fund (GF) and other international funders. We
are concerned that current funding mechanism for HIV programs in Uganda may be difficult to sustain and as
service providers we are keen to explore ways in which provide lifelong HIV care to as many people living with HIV
(PLHIV) as possible. Until such time as the Ugandan economy can support universal, state-supported,
comprehensive healthcare, bridging alternatives must be considered. We suggest that offering patients with the
sufficient means to assume some of the financial burden for their care in return for more convenient services could
be one component of increasing coverage and sustaining services for those living with HIV.
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Background
Since 1990, 458 billion United States dollars (USD) has
been spent in development aid for health. This aid
comes primarily from donor governments and philan-
thropic organizations. Of this, 23.2 % was targeted for
HIV/AIDs treatment and support [1]. Whilst multi-
lateral funding for HIV/AIDS dramatically increased
from 2004 to 2008, it has largely plateaued in the last
8 years, with a drop in 2010 and marginal 1 % increase
from 2013 to 14 [2]. Across sub-Saharan Africa, up to
20 % of total spending on health is used for HIV
services, and of this over 85 % is estimated to come from
international funding rather than in-country sources [3].
Uganda is among 51 countries that rely on international
sources to fund over 75 % of their HIV response; over
20 donors contribute over USD 400 million annually [4].
There were an estimated 1,500,000 people living with
HIV in Uganda in 2012 and by the end of June 2013
567,000 eligible persons were estimated to be receiving
ART. Unfortunately despite the scale up of HIV services
in Uganda, there is an increased HIV prevalence (from
6.8 % in 2001 to 7.2 % in 2012) and only 40 % of people
eligible for ART are currently receiving it [5]. Even at
this level of ART coverage the fiscal liability for
Uganda to maintain services for all those who are
currently receiving it is estimated to be as much as
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3 % of GDP [5, 6]. In order to meet the growing need of
increased patient numbers and further ART coverage the
projected costs of comprehensive HIV care and treatment
services will increase substantially. Whilst this has been
deemed to be cost effective in modeling in sub-Saharan
African epidemics (Zambia, South Africa) expansion of
ART coverage to those with CD4 counts over 350 cells/ul
will still cost between $237 to $1691 per DALY averted
[7]. Consequently the sustainability of these services is ex-
tremely uncertain, as international funding has plateaued
and there is no clear long term plan for the Government
of Uganda (GOU) to fill the potential gap. This is com-
pounded by the growing view that HIV/AIDS care gets a
disproportionate allocation of national health resources
relative to other chronic conditions and that it should be
“normalized” so that the financing model for HIV/AIDs
more closely reflects the economic and social reality of
Uganda. This article reviews the current literature on
sources of HIV service financing in Uganda and the
possible options to expand and sustain life-long HIV treat-
ment in Uganda.
Models of access to health care and HIV services
in Uganda
Table 1 summarizes the ongoing local financing models
in Uganda. It describes the current status of these op-
tions mentioned above, and the action required from
stakeholders to expand and strengthen these options.
Free at point of delivery
Following the abolition of user fees in Uganda in 2001
[8], health care at government clinics is free at the point
of delivery, for a menu of selected services (mainly out-
patient) and informal charging for additional add on ser-
vices which are sometimes present. This could be
termed a “publically provided health insurance” financed
by taxes and other sources of government revenue. The
Ministry of Health aim is to provide all necessary HIV/
Table 1 Future HIV financing options for PNFPs
Option Current status Government action required PNFP action required
Direct Government funding
of services and/or centralized
HIV/AIDS Fund [2, 6, 10]
Inadequate resources and
inadequate budget allocation
• Streamlined, transparent
public- private partnership
(PPP) frameworks for health
• Long term budget
commitment
• Engagement of donors for
medium term budget support
• Innovative tax/revenue collection
and allocation measures
• Stronger accountability and performance/
quality measurement systems
• Systems to meet minimum public
private partnership guidelines
• Less vertical /“silo” based programs
• Health system wide capacity building
• Quality Assurance and Performance
measurement systems
National Health Insurance
Scheme [6, 11, 13]
In discussion • Stakeholder involvement; generating
a consensus on nature and scope
of coverage
• Fund management capacity
• Governance, accountability and
confidence building
• Legislation and regulation
• Definition and implementation of
systems to meet minimum NHIS
requirements for PNFP providers
• Capacity building for NHIS compliance
• Quality Assurance and Performance
measurement systems
Out-of-Pocket Service Currently funds 50 % of
health care [32]
• Stronger accountability and performance/
quality measurement systems
• Direct cash transfers
• Quality Assurance and Performance
measurement systems
Private Insurance [16, 17] Very low coverage, inadequate
regulation
• Stronger Regulation
• Stronger accountability and performance/
quality measurement systems
• Creating an attractive business
proposition for private insurance firms
• Creating systems to meet minimum
private health insurance company
requirements
Community Health Insurance
Schemes [11]
Very low coverage, inadequate
regulation
• Legislation and regulation • Community engagement and
confidence building
• Community accountability mechanisms
• Differentiated care for scheme members
Co-Payment to subsidize
overall costs of care
Used mainly by faith based
organizations and NGOs, but
little documentation on
coverage and best practices
• No additional legislation and/or
regulation
• Creating capacity to manage and
report separate (paying and non-paying
client) income streams
• Mobilizing paying and non-paying
client support
• Mobilizing external stakeholder (eg
donor and government) support
• Maintenance of standard quality
care for all clients
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AIDS services free in the 2655 government health facil-
ities it owns and manages [9]. However, the total health
allocation in the national budget fell from 8.3 % in FY
2011/2012 to 7.4 % in FY 2012/2013 which means that
the overall level of expenditure on health is significantly
below the Abuja target of a 15 % allocation of a govern-
ment’s budget to health [10], and finding sufficient fund-
ing for HIV and other health services is a challenge.
The GOU has taken some steps to introduce a National
Health Insurance Scheme (NHIS) since 1995, but this has
made little progress largely due to negative stakeholder in-
fluence [11]. Even if it was implemented, it’s not clear how
the NHIS in its current proposed form would incorporate
existing health financing systems in order to avoid frag-
mentation and create mechanisms for cross-subsidization
[12]. Moreover, feasibility studies generally point to public
mistrust, as well as a lack of key systems and capacities
(particularly relating to governance and accountability) to
implement the NHIS scheme in Uganda which would
need to be addressed [13].
Out-of-pocket financing
In addition to government clinic there are 994 private for
profit (PFP) and 801 private not for profit (PNFP) (includ-
ing faith based) health facilities, of varying quality, size and
geographical distribution [9]. The 2010 National Health Ac-
counts (NHA) Study in Uganda for health expenditures es-
timated that 50 % of health expenditure came from private
funds (42 % from households) [14]. Many people seek HIV
services with a fee for service in PFP and PNFP facilities
and factors associated with this include distance to service
provided, perceived better quality of service and avoidance
of long waiting times [15].
Health Insurance
Data on health insurance is challenging to come by. In
2004 WHO estimated 0.2 % of total health expenditure
was on private medical insurance [16]. Estimates from
2008 suggest that only 0.5 % of the population in Uganda
has any health insurance coverage [12]. Private health in-
surance schemes cover only 0.2 % of the population and
are largely available only for people in formal employment
whose employers subsidize the cost [17]. The 30 registered
community insurance schemes in Uganda are mostly
health facility-based schemes in which premiums are paid
by individual community members. These schemes cover
only an estimated additional 100,000 people (about 0.3 %
of the current population) [8].
Current Sources of funding and future options for
HIV/AIDs services in Uganda
Government funding
In FY 2012/2013 the GOU spent 7.4 % of its total annual
budget on financing health systems, in particular human
resources in the health sector, on which the delivery of
HIV/AIDs services relies heavily. Of this only about 3 %
of the health budget is for targeted to HIV/AIDS pro-
grammes, but the remainder of this funding indirectly
supports HIV programmes through government health
systems strengthening. Policy innovations to increase the
budget for health (and specifically for HIV services) are
being considered such as an HIV tax on selected services
and/or a cash transfers.
The President’s Emergency Plan for AIDS in Africa
(PEPFAR) funding
The United States government Presidents Emergency
Fund for AIDS Relief (PEPFAR) funded programs
invested over $1.8 billion in HIV-related financing for
Uganda between 2004 and 2011. PEPFAR currently con-
tributes over 85 % of the national HIV response through
projects implemented by international and local organi-
zations (PNFP organizations) which provide free HIV/
AIDS services or significantly support such services at
public facilities. In practice, this means PNFPs housed
within government health facilities, but running a siloed
service, with directly employed health care workers but
reporting to the national Ministry of Health system
through the Health Information Management Service
(HMIS). PEPFAR funding has already plateaued and
PEPFAR now requires “cost-sharing assurances” from
governments [18]. As governments assume more cost-
sharing commitments, PEPFAR plans to more actively
cede control over priority-setting and accounting for re-
sults to partner countries.
Global Fund (GF) and other funders
Since its inception, the Global Fund to Fight AIDS, Tu-
berculosis and Malaria (Global Fund) has disbursed over
USD 230 million to support various aspects of HIV/
AIDS programs in Uganda through government and civil
society mechanisms [19]. While the Global Fund has
mainly utilized the mainstream government channels for
delivering its support for the HIV effort, a substantial
part of downstream resources that it provides (particu-
larly ARVs) are delivered either directly through PNFPs
or with significant support from PNFPs at government
facilities [20]. The Global Fund has prioritized lower in-
come, high burden countries and streamlined the fund-
ing application process through its new funding
mechanism to make funding more predictable and
flexible [21]. Nonetheless, developed country contri-
butions to the Global Fund and other funding mecha-
nisms are on a downward trend, triggering similar
cutbacks in funding to many countries’ HIV pro-
grams. This signals potential exposure to the risk of a
serious financing gap particularly for PNFPs providing
free HIV services to the public.
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The case for voluntary co-pay: Can Ugandans help
each other to pay for HIV care?
A National Health Insurance scheme that integrates all
available external, private and public providers and fi-
nancing agencies would create the opportunity reduce
administrative costs, create less fragmented, full service
provision points, and provide the impetus for introduc-
tion of comprehensive cross-subsidized contributory fi-
nancing for health in general and HIV services in
particular. However, in reality this may not be developed
in time to fill the gap between drop in multi-lateral do-
nations and a definite government commitment to fund-
ing for HIV services. As PNFP we are front line
providers of HIV care. As such our organization as well
as others will feel the early effects of a reduction or plat-
eauing in funding, and will be unable to expand our ser-
vices further, or will need to cut back. We believe that
the option that may be most expedient for PNFP pro-
viders such as ourselves to continue to provide care in
the short term is development of voluntary co-pay ser-
vices. Uganda has an improving economy with a rising
middle class; the number of Ugandans in the middle
class (defined as those whose ability to meet their basic
needs is relatively stable and who can afford to save for
the future) increased from1.8 million 1992 to 12.6 mil-
lion in 2012 (10 to 37 % of the population) [22]. In
Uganda the 2011 AIDS indicator survey found that HIV
prevalence increases with higher socio-economic status
[23], and many of these PLHIV will access care in the
private sector due to reduced waiting times and longer
opening hours. However, the private health sector which
already charges a fee for service, is a profit making sec-
tor, which has no obligation to help the lower income
strata. In addition, as they are independent of the gov-
ernment system there is no quality control on their care
[24], records are often absent and retention in care is
poor [25].
We suggest that as a short term measure to mitigate
against the emerging risk of financing gaps, PNFPs could
explore the introduction of voluntary co-pay schemes so
that those who can afford pay for services that can help
subsidize the cost for those who cannot afford to pay.
However, previous experience with co-pay systems both
within the general health service suggest that they may
affect utilization of services, as in Uganda, their abolition
in 2001 increase attendance at health clinics [26]. Of par-
ticular concern in HIV care is lack of adherence to ART
drugs and development of drug resistance, which has been
noted when patients are paying for care [27, 28].
Therefore, in order mitigate against these issues, and
to maintain a reasonable level of equity, we propose that
such schemes could differentiate services through con-
venience and accessibility, whilst maintaining essential
services at an acceptable standard for both groups of
clients. For example, patients pay a standard cost for
consultation in order to see the same doctor at each ap-
pointment or to access care at weekends or evenings,
but are not charged for tests or medication. At the Infec-
tious Diseases Institute in Kampala we are currently
studying the feasibility of this concept by piloting a co-
pay component to our large, multidisciplinary HIV
clinic. A routine customer care survey of 387 of our
8500 patients suggested that over 40 % would be willing
to pay a fee for greater convenience with longer (after
work) opening hours and shorter waiting times. Qualita-
tive research in our clinic has shown general acceptabil-
ity of some patients for co-pay services for convenience,
and also a willingness of those patients to contribute to
the cost of care for other patients with less resources
[29] and preliminary data suggests that access to a co-
pay clinic improves retention to care in those who were
lost to follow up within the private sector [30]. However,
we will need to determine if this model is actually cost
saving and can contribute funds to support sustaining of
services, as previous experience with user fees in Africa
suggest administration costs can be greater than fees
collected [31].
Conclusion
We are concerned that current funding mechanism for
HIV programs in Uganda is not sustainable and as ser-
vice providers we are keen to explore ways in which pro-
vide lifelong HIV care to as many people living with HIV
(PLHIV) as possible. In reality, it is likely that only a
model that combines several different financing ap-
proaches will provide the necessary care and treatment
for our PLHIV in the future. Until such time as the
Ugandan economy can support universal, state-
supported, comprehensive healthcare bridging alterna-
tives must be considered. We suggest that offering pa-
tients with the sufficient means to assume some of the
financial burden for their care in return for more con-
venient services could be one component of preparing
for a “Post-PEPFAR” funding environment. We urge
other care providers to share their ideas and experiences
in sustaining services so that we can learn from best
practices of others in maintaining and expanding quality
HIV services in resource limited settings.
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